Valeria Grancini
Overview
Explore the profile of Valeria Grancini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gaglio A, Grancini V, Giacchetti F, Mirani M, Orsi E, Resi V
Nutrients
. 2025 Jan;
17(1.
PMID: 39796606
Background: Globally, the progressive increase in the aging population has led to social and health problems associated with age-related chronic diseases, such as type 2 diabetes mellitus (T2DM) and sarcopenia....
2.
Resi V, Gaglio A, Pigotskaya Y, Caretto A, Orsi E, Grancini V
Healthcare (Basel)
. 2025 Jan;
13(1.
PMID: 39791645
The management of type 1 diabetes in pregnancy with new technologies is challenging. Sometimes the complexity of new-generation systems such as "continuous subcutaneous insulin infusion, CSII" and patient or provider...
3.
Grancini V, Cogliati I, Gaglio A, Alfieri C, Castellano G, Orsi E, et al.
Acta Diabetol
. 2024 Nov;
PMID: 39611868
No abstract available.
4.
Garofolo M, Vitale M, Penno G, Solini A, Orsi E, Grancini V, et al.
Cardiovasc Diabetol
. 2024 Oct;
23(1):377.
PMID: 39449120
Background: A Chronic Kidney Disease (CKD) Epidemiology Collaboration (EPI) formula not including a Black race coefficient has been recently developed and is now recommended in the US. The new (2021)...
5.
Grancini V, Cogliati I, Gaglio A, Resi V, Orsi E
Acta Diabetol
. 2024 Jul;
61(11):1483-1489.
PMID: 38981873
Cystic fibrosis (CF)-related diabetes (CFRD), characterized by partial to complete impaired insulin secretion, is the most common extra-pulmonary complication of CF. Actually, insulin is the only approved therapy for its...
6.
Alfieri C, Campioli E, Fiorina P, Orsi E, Grancini V, Regalia A, et al.
Nutrients
. 2024 May;
16(10).
PMID: 38794758
This study aimed to investigate the prevalence and determinants of glucose metabolism abnormalities and their impact on long-term clinical outcomes in kidney transplant recipients (KTxps). A retrospective analysis of 832...
7.
Grancini V, Cogliati I, Gaglio A, Resi V, Orsi E
Front Endocrinol (Lausanne)
. 2024 May;
15:1392371.
PMID: 38779453
The incidence of acute pancreatitis (AP) in liver transplanted people is reported to be 1.5-8%. On the other hand, the evidence for a causal relationship between glucagon-like peptide 1 receptor...
8.
Vitale M, Orsi E, Solini A, Garofolo M, Grancini V, Bonora E, et al.
Acta Diabetol
. 2024 May;
61(9):1107-1116.
PMID: 38714557
Aims: It is unclear whether type 2 diabetes diagnosed in young adulthood is associated with increased severity than that occurring later in life beyond longer lifetime exposure to hyperglycemia. This...
9.
Grancini V, Cogliati I, Alicandro G, Gaglio A, Gatti S, Donato M, et al.
Front Endocrinol (Lausanne)
. 2024 Mar;
15:1359960.
PMID: 38505744
Introduction: One of the most common complications of cirrhosis is diabetes, which prevalence is strictly related to severity of hepatopathy. Actually, there are no data on the persistence of post-transplant...
10.
Lombardi R, Mantovani A, Cespiati A, Francione P, Maffi G, Del Zanna E, et al.
Dig Liver Dis
. 2023 Oct;
56(4):551-558.
PMID: 37845152
Background And Aims: Patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are at high risk of hepatic fibrosis. To prospectively evaluate changes in fibrosis in...